Policy

Corporate Social Responsibility (CSR) Policy Inborn BioMedical 2025 Introduction At Inborn, we are dedicated to responsible innovation in biomedical materials for the treatment of bone diseases. Our research and development in bone-mimicking hydroxyapatite and gelatin-based colloidal gels aim to improve patient outcomes while maintaining ethical, sustainable, and socially responsible practices. This CSR policy aligns with […]